Rare Variant Analyses In 51,256 Type 2 Diabetes Cases and 370,487 Controls Reveal the Pathogenicity Spectrum of Monogenic Diabetes Genes

Rare Variant Analyses In 51,256 Type 2 Diabetes Cases and 370,487 Controls Reveal the Pathogenicity Spectrum of Monogenic Diabetes Genes2025-02-06T19:35:26-05:00

The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.

© 2023 Center for Genomic Medicine

Go to Top